MEMORANDUM OPINION
This case presents a broad constitutional attack on a significant federal environmental program. Plaintiff General Electric Company (“GE” or “plaintiff’) challenges the U.S. Environmental Protection Agency’s (“EPA”) administration of section 106 of the Comprehensive Environmental Response, Compensation, and Liability Act (“CERCLA” or “the Act”), 42 U.S.C. § 9601 et seq. GE contends that EPA’s “pattern and practice” of administering section 106, 42 U.S.C. § 9606, violates the Due Process Clause of the Fifth Amendment. Am. Compl. at ¶ 1. Before the Court are the motions for summary judg *11 ment of GE and EPA and its administrator, Lisa Jackson. 2 For the reasons that follow, the Court rejects GE’s novel, but substantial, challenge. On the record presented, the administrative order regime under section 106 of CERCLA, as administered by EPA, does not offend due process.
BACKGROUND
1. The CERCLA Framework 3
CERCLA was enacted to ensure efficient and expedient clean-up of hazardous waste sites resulting from industrial pollution.
See Key Tronic Corp. v. United States,
EPA has several options if negotiations fail. One option is to perform the clean-up itself, paying for it out of the so-called “Superfund” established by Congress for this purpose. EPA would then bring an action in federal district court under section 107 of CERCLA to recover clean-up costs from responsible parties. Id. §§ 9607(a)(4)(A), 9611(a). Another option is to seek an order from a federal district court compelling a responsible party to clean up a hazardous site. Id. § 9606(a). EPA’s third option is to issue a “unilateral administrative order” (“UAO”) under section 106, ordering PRPs to clean up a site. Id. EPA may issue a UAO upon a finding “that there may be an imminent and substantial endangerment to the public health or welfare or the environment because of an actual or threatened release of a hazardous substance from a facility.” Id. EPA’s practice of issuing UAOs under section 106 is at the heart of GE’s due process challenge in this case.
Under CERCLA, a PRP that believes it is not responsible for the clean-up faces a choice whether or not to comply with a UAO. If the PRP complies, it may seek reimbursement from other PRPs or from EPA itself upon completion of the cleanup.
Id.
§ 9606(b). If the PRP does not comply, then EPA must file a civil action in federal district court to enforce the UAO.
Id.
§ 9606(a). The court reviews EPA’s remedy selection (i.e., its selection of a UAO) under the Administrative Procedure Act’s “arbitrary and capricious” standard.
See id.
§ 9606(b)(2)(D). The court reviews EPA’s selection of the responsible party
de novo. See Kelley v. EPA,
EPA may seek two kinds of monetary penalties if a PRP does not comply with a UAO. First, if the noncomplying PRP *12 lacks “sufficient cause” and willfully violates the order, then EPA may seek $32,500 for each day of noncompliance. Id. § 9606(b). Second, EPA may seek punitive damages up to three times “the amount of any costs incurred by the [Superfund] as a result of such failure to take proper action.” Id. § 9607(c)(3). But these penalties are not automatic under CERCLA. If the reviewing court finds that the PRP had sufficient cause for noncompliance, then it cannot impose either form of penalty. Id. §§ 9606(b), 9607(c)(3). Even absent a finding of sufficient cause, moreover, the court has complete discretion as to the imposition and amount of any penalty. Id. § 9607(c)(3).
II. Procedural History
GE filed its Complaint on November 28, 2000, and amended it on March 14, 2001. GE challenges CERCLA in two ways. First, GE alleges that the text of CERC-LA itself facially violates the Due Process Clause. Am. Compl. at ¶¶ 21-28, 50, 54. Second, GE alleges that EPA’s “pattern and practice” of administering the UAO regime under section 106 violates GE’s due process rights. Id. at ¶¶ 17-20, 51-52, 54.
In March 2001, EPA moved to dismiss GE’s Amended Complaint on jurisdictional grounds. EPA argued that this Court lacked subject matter jurisdiction because section 113(h) of CERCLA bars judicial review of a section 106 order until the clean-up is complete. This Court agreed and granted EPA’s motion to dismiss.
General Electric I, 257
F.Supp.2d at 12. On appeal, however, the D.C. Circuit reversed and instructed this Court to consider the merits of GE’s due process challenge on remand.
General Electric II,
In May 2004, EPA filed a motion for summary judgment. EPA argued that GE’s challenge was solely a facial one and that it had to be analyzed under the
Salerno
doctrine.
See United States v. Salerno,
This Court disagreed, however, that GE’s facial and “pattern and practice” claims were one and the same.
See id.
at 333-36. EPA argued that when the court of appeals remanded the case to this Court, it had held that only facial claims cleared the section 113(h) jurisdictional hurdle. Therefore, EPA reasoned, only GE’s facial challenge was before this Court on remand. To be sure, this Court recognized that some isolated language from the D.C. Circuit’s opinion did support EPA’s position. But the D.C. Circuit’s opinion, read as a whole, firmly undercut that position. This Court noted that the court of appeals clearly distinguished between facial, systemic, and particularized challenges.
Id.
at 334 (citing
General Electric II,
The Court found this key point inescapable given the cases that the court of appeals relied upon in reaching its holding.
General Electric III,
Discovery lasted over two years, closing in August 2007. During the course of discovery, the Court issued rulings on motions to compel in September 2006 and February 2007.
See General Electric v. Johnson,
No. Civ.A.00-2855,
Before the Court at this time are the parties’ cross-motions for summary judgment based on that record. The crux of GE’s argument is that EPA’s administration of section 106 violates the Due Process Clause because, applying the framework of
Mathews v. Eldridge,
LEGAL STANDARD
Summary judgment is proper when the pleadings and evidence demonstrate that “there is no genuine issue as to any material fact and that the moving party is entitled to judgment as a matter of law.” Fed.R.Civ.P. 56(c). The moving party may successfully support its motion by “informing the district court of the basis of its motion, and identifying those portions of ‘the pleadings, depositions, answers to interrogatories, and admissions on file, together with the affidavits, if any,’ which it believes demonstrate the absence of a genuine issue of material fact.”
Celotex Corp. v. Catrett,
ANALYSIS
I. Applicability of Salerno.
EPA argues that the standard from
United States v. Salerno,
The Court will not apply the
Salerno
standard to GE’s pattern and practice claim.
5
Salerno
applies to challenges based on hypothetical applications of a statute, not to challenges based on the particular facts of a case.
See Salerno,
II. Standing
EPA next argues that GE lacks standing to raise injuries based on noncompliance with a UAO.
6
See EPA Reply Memorandum in Support of its Summary Judgment Motion (“EPA Rep.”) at 9-11. Standing “requires a plaintiff to demonstrate the now-familiar elements of injury in fact, causation, and redressability.”
Lance v. Coffman,
The injuries relevant to standing are not, as EPA asserts, injuries arising from an act of noncompliance. The thrust of GE’s argument is that EPA’s administration of section 106 so amplifies the risks and costs of noncompliance that no rational PRP would choose not to comply with a UAO. The argument thus responds to this Court’s holding in
General Electric III,
where the Court rejected GE’s textual challenge to section 106 in part because a PRP theoretically can choose not to comply with a UAO.
The injury inquiry for standing is limited to whether GE has “set forth” sufficient “specific facts” to support its claim that EPA deprives GE of liberty or property without due process by issuing UAOs to GE.
See Lujan,
III. Ex Parte Young
GE’s first claim is that EPA’s pattern and practice of administering section 106 violates procedural due process under
Ex parte Young,
GE’s pattern and practice claim under
Ex parte Young
fails for the same reasons previously explained. GE points to four aspects of EPA’s UAO policy that supposedly intimidate PRPs into compliance: EPA seeks maximum penalties for noncompliance; EPA seeks multiple penal
*18
ties for violations at a single UAO site; EPA rejected Justice Department advice that EPA should impose a cap on daily-penalties; and EPA labels noncomplying PRPs as “recalcitrant.” But no matter what EPA arguably does or seeks, a
judge
ultimately decides what, if any, penalty to impose.
9
Indeed, courts routinely exercise their discretion in determining what kinds of daily or punitive penalties to impose for violations of section 106.
See, e.g., United States v. Capital Tax Corp.,
Civ.A.No. 04-4138,
Nor does EPA’s pattern and practice regarding UAOs prevent federal courts from exercising their discretion. In
General Electric III,
this Court affirmed as satisfying due process requirements CERCLA’s judicial review provisions, which provide for
de novo
review of liability and review of remedy selection under an “arbitrary and capricious” standard.
Finally, GE argues that EPA has purposefully muddied the contours of the sufficient cause defense, thus keeping PRPs guessing whether they have sufficient cause in deciding not to comply with a UAO. To be sure,
Ex parte Young
problems may arise when the imposition of penalties turns on the interpretation of an imprecise legal standard.
See Solid State Circuits,
*20 IV. Mathews v. Eldridge
That brings us to the primary due process challenge GE asserts, which must be assessed within the framework of
Mathews v. Eldridge.
Both EPA and GE propose broad rules for certain categories of deprivations or government actions. But courts approach due process claims with scalpels, not cleavers.
See Hannah v. Larche,
GE argues that due process requires a trial-type hearing for non-emergency, “adjudicatory” agency decisions. GE Mem. at 10; GE Reply Memorandum in Support of its Summary Judgment Motion (“GE Rep.”) at 23. GE insists that this Court held in
General Electric IV
that issuance of a UAO is an adjudicatory decision.
See
EPA, on the other hand, argues that “consequential” deprivations cannot form the basis for a due process challenge at all. EPA Opp. at 9-10. EPA points out that some of the deprivations GE alleges only occur because the marketplace values a PRP less after EPA issues a UAO to that PRP. In support of its proposed rule, EPA relies on
O’Bannon v. Town Court Nursing Center,
Connecticut v. Doehr,
Finally, EPA argues that mere “diminution in value” does not give rise to a due process claim. EPA Mem. at 24-25. EPA cites only to
Andrus v. Allard,
Having rejected the parties’ proposed easy solutions, the Court must apply the well-settled
Mathews v. Eldridge
framework for due process claims. Under
Matheivs,
courts balance the private interests, the governmental interests, and the risk of error to determine whether existing procedures are adequate to satisfy constitutional due process requirements.
PRPs arguably suffer deprivations without adequate due process under the section 106 UAO regime in three ways. First, the mere issuance of a UAO — before the PRP decides whether to comply — arguably impacts the PRP’s stock price and brand value. Second, if a PRP chooses not to comply with a UAO, then the PRP arguably suffers increased damage to its stock price and brand value. Noncompliance also may impair a PRP’s relationships with regulatory personnel and stakeholders, potentially depriving the PRP of a liberty interest. Finally, if a PRP chooses to comply with a UAO — and GE argues here that PRPs are forced to do so — then the PRP must incur the costs of clean-up. The parties agree that clean-up costs constitute a protected property interest; the parties disagree, however, on whether PRPs are forced to comply. 12
A. Mathews Prong One
1. Deprivations at UAO Issuance
The parties dispute whether GE is required to show that a PRP suffers a deprivation when a UAO is issued or when a PRP elects not to comply with it. EPA contends that GE is required to show that PRPs suffer injuries at issuance. EPA *22 Opp. at 12. GE argues that the relevant deprivations are those at noncomplianee because the parties agree that there is a deprivation at compliance. GE Rep. at 12. Nevertheless, GE submits that even though it focused on costs at noncompliance, its expert, Dr. John Geweke, has established that “issuance of a UAO would cause an immediate deprivation, whether or not a PRP complied.” Id. Issuance of a UAO arguably causes two kinds of property deprivations: (1) reduced stock price and increased cost of financing; and (2) damage to the PRP’s brand value.
Neither stock price/cost of financing impacts nor brand value depletions are protected property interests upon mere issuance of a UAO. Damage to stock price and brand value could occur anytime any agency takes any action that the market interprets as adverse against a company. For example, if the Securities and Exchange Commission announced an investigation of a company for securities fraud, that company’s stock price and brand value might suffer. The same would likely occur if the Food and Drug Administration announced that it was recalling a company’s drug because of health concerns. But surely neither of those situations triggers due process concerns. Indeed, announcement of the very pre-issuance process that GE seeks would adversely impact a PRP’s stock price and brand value under GE’s argument. The Court would be inviting a host of unfounded due process claims were it to conclude that stock price and brand value damage upon mere issuance of a UAO constitute actionable property deprivations. Counsel for GE recognized the need for line-drawing at the October 14, 2008 motions hearing before the Court, but counsel proposed drawing the line at noncompliance, not at issuance. Tr. at 17-19. Accordingly, GE has not shown that PRPs suffer any deprivation of a protected property interest simply upon issuance of a UAO.
2. Deprivations if a PRP Does Not Comply
GE argues that PRPs are deprived of property and liberty if they elect not to comply with a UAO. GE points to three kinds of deprivations at noncompliance. GE again asserts that PRPs suffer injuries relating to their stock price and cost of financing. GE also reprises its argument that PRPs incur brand value damage. Finally, GE argues that PRPs’ relationships with stakeholders and EPA itself are impaired if PRPs do not comply, thereby depriving PRPs of a protected liberty interest.
As a threshold matter, GE’s stock price/ cost of financing and brand value reduction arguments do not suffer from the same line-drawing problems at the noncompliance stage that doomed them at the issuance stage. As counsel for GE put it, “the axe falls” at noncompliance. See Tr. at 17. That is true because a PRP is normally branded a recalcitrant actor once it decides not to comply — -a label that enhances the harm to stock price and brand value, and also supposedly exposes PRPs to greater penalties, increases permitting times, bars PRPs from certain EPA programs, and impacts PRPs’ relationships with certain stakeholders. The deprivations are thus both qualitatively and quantitatively different upon noncompliance than upon issuance of a UAO. These differences are sufficient to distinguish the impact of noncompliance with a UAO from the theoretical impacts of other types of adverse government action.
GE bases its stock price/cost of financing argument on the expert reports from Drs. John Geweke and Jason Johnston. Dr. Geweke, faced with a dearth of data regarding the impact of noncompliance on *23 stock price, instead examines the impact of “special notice letters” on stock price for 290 publicly-traded companies in 1994. Geweke Report at ¶ 13. Dr. Geweke also looks at the impact of special notice letters on bond yields for 89 companies from 1995 to 1998. Id. EPA usually sends special notice letters to PRPs to initiate settlement discussions regarding clean-up of a hazardous site. EPA’s Statement of Facts (“EPA SOF”) at ¶¶ 19-20. If settlement fails, then EPA normally issues a UAO. Id. at ¶ 27. Therefore, Dr. Geweke concludes, special notice letters associate a PRP with a contingent liability and negatively impact stock price and cost of financing. Geweke Report at ¶ 6. Using two multivariate regression analyses, Dr. Geweke then extrapolates what the impact on stock price and cost of financing would be if a PRP chose not to comply with a UAO. Logically, contingent liabilities associated with noncompliance are greater than those associated with a special notice letter because EPA may seek treble and punitive damages if a PRP chooses not to comply. Therefore, Dr. Geweke concludes that “[a] firm’s decision not to comply with a UAO ... subjects the firm to a loss in market value that is 5.9 times greater than its loss in market value arising from a special notice letter.” Id. at ¶ 19. He calculates that the average decrease in market value based on noncompliance would be $76.4 million, compared with an average $12.9 million decrease in market value based on receipt of a special notice letter. Id. at ¶ 158 & Figure 7.
Dr. Johnston takes a different approach. Like Dr. Geweke, Dr. Johnston does not have sufficient data to analyze the impact of noncompliance on stock price. Rather than focusing on special notice letters, however, Dr. Johnston also looks at the impact of other “negative environmental events” on a company’s stock price, such as EPA’s filing of a complaint against a company or a company’s settlement of a Justice Department lawsuit. See Johnston Report at ¶¶ 34-37. Dr. Johnston does not conduct regression analyses. Instead, he surveys four existing “event studies” that test the relationship between negative environmental news and a stock price decrease. See id. at ¶ 29 (explaining the event study methodology). Dr. Johnston concludes that these event studies provide “strong evidence” that noncompliance with a UAO will result in “statistically significant negative abnormal stock market returns” for a targeted PRP. Id. at ¶ 33. Because Dr. Johnston does not conduct his own event study, he does not project the size of a potential noncompliance-based stock price decrease.
EPA asserts that Dr. Geweke’s analysis fails under the standard governing the admissibility of expert opinion evidence.
See Daubert v. Merrell Dow Pharms., Inc.,
EPA next questions the assumptions underlying Dr. Geweke’s analysis.
See
EPA Opp. at 13-14. EPA highlights three supposedly flawed assumptions: that firms that are issued UAOs at multiple sites will decide not to comply with any UAO; that firms that choose not to comply with a UAO will be assessed maximum daily penalties for a five-year period
(i.e.,
that EPA will not bring an enforcement action until the statute of limitations is set to expire); and that the markets do not discount contingent liabilities based on the likelihood of enforcement, the chance that a PRP will successfully defend an enforcement action, or the possibility that a court will impose a smaller penalty than EPA requests. Although not without some force, none of these alleged flaws is sufficient to disqualify Dr. Geweke’s report. His model does calculate potential impacts if a PRP receives multiple UAOs and does not comply with any of them, but he reaches his main conclusion — that the average decrease in market value based on UAO noncompliance is $76.4 million — by assuming that a PRP decides not to comply with a single UAO.
See
Geweke Report at ¶ 158. Moreover, EPA does not meaningfully dispute GE’s assertion that “[i]t is the government’s practice in bringing suit for UAO noncompliance to seek the statutory maximum in penalties and treble damages.”
See
GE’s Statement of Undisputed Facts (“GE SUF”) at ¶ 125 and EPA’s Response to GE SUF at ¶ 125. While the Court is persuaded that EPA has a policy of seeking maximum damages, GE has not offered any evidence to suggest that EPA routinely waits as long as possible before filing a cost recovery or enforcement action. The Court, then, will not hazard a recalculation of Dr. Geweke’s formula. But it is clear that shorter delays in filing cost recovery or enforcement actions would result in smaller potential penalties, smaller contingent liabilities, and, therefore, an average market value reduction of less than $76.4 million. Similarly, while Dr. Geweke specifically acknowledges that the market may discount potential liabilities based on possible defenses or a court’s decision to impose smaller penalties than EPA seeks, he argues that “the difference would be one only of magnitude.” Geweke Report at ¶ 27. True enough, but because he did not attempt to quantify how much markets would discount potential liabilities, his $76.4 million calculation is necessarily too high. The question at this stage of the inquiry, however, is whether a deprivation exists, not how large that deprivation is.
See Sullivan,
EPA also asserts that Dr. Johnston’s report fails the Daubert standard. EPA Opp. at 14-15. EPA again contends that Dr. Johnston should have examined hard data rather than similar “negative environmental events.” But Dr. Johnston, like Dr. Geweke, could not examine actual instances of noncompliance with UAOs because there are not enough to comprise a reliable data set. EPA next argues that *25 Dr. Johnston should have conducted his own event study rather than relying on previously-published ones. That argument has merit. Although none of the cases EPA cites support its argument that Dau-bert requires experts to conduct their own event studies, 13 Dr. Johnston’s reliance on other economists’ analyses of other (albeit comparable) events certainly diminishes the probative value of his expert report. Dr. Johnston equates UAO noncompliance to these other events — such as EPA’s announcement of a settlement or a newly-filed lawsuit — by reasoning that “UAOs are ‘one of the primary enforcement tools to obtain a ... response by PRP’s,’ and are used to ‘provide an incentive for PRP’s to settle’ or to ‘force commencement of work at the site when settlement cannot be reached.’ ” Johnston Report at ¶ 32 (quoting USEPA, OSWER Directive No. 9833.0-la-3 (March 1990)) (ellipsis in original). But Dr. Johnston does not explain why UAOs are like any of the specific events that the other event studies examine. His conclusion — that negative environmental events are associated with large stock market decreases and that a UAO is a negative environmental event — is equally vague. Thus, Dr. Johnston’s report largely duplicates Dr. Geweke’s conclusions, only in a more general and imprecise way. The Court will not give significant weight to vague, cumulative evidence. See Fed. R.Evid. 403. Hence, the Court finds that Dr. Johnston’s report does not advance GE’s argument that noncompliance with a UAO causes a decrease in stock price.
The second proffered deprivation is GE’s contention that a PRP’s brand asset is damaged if it does not comply with a UAO. Intangible assets, like a brand name, may receive due process protection.
See Delaware, Lackawanna & W. R.R. Co. v. Pennsylvania,
For firms that have made substantial investments in establishing a corporate brand name for strong environmental performance, events that weaken the firm’s brand name as an environmentally responsible actor cause a definite and potentially large decrease in the value of the corporate environmental brand asset. ...
Johnston Report at ¶ 15. This time, Dr. Johnston does not apply any scientific methodology to test his conclusion. His report, however, is salvaged because no one disputes his conclusion. Not even Dr. Siegel, EPA’s rebuttal expert, takes issue with it.
See, e.g.,
Siegel Dep. at 70:11-70:14, 72:10-72:16, 73:6-73:10, and 79:13-79:17. More controversial is how
much
noncompliance with a UAO decreases the value of the brand asset. While Dr. Johnston opines that the decrease is “potentially large,” EPA correctly points out that Dr. Johnston has no data to support his conclusion. But, again, at this stage of the
Mathews
analysis, only the
existence
of a pre-hearing deprivation matters, not its magnitude.
See Sullivan,
*26
Finally, GE argues that PRPs suffer pre-hearing liberty deprivations under the D.C. Circuit’s “reputation-plus” standard. This standard has its origins in
Paul v. Davis,
Collateral consequences are “sufficiently formal or sufficiently broad” when the reputation-injuring statement automatically triggers some adverse effect or precludes the injured party from pursuing chosen categories of activities in a way “equivalent in every practical sense to formal debarment.”
See Trifax Corp. v. District of Columbia,
GE argues that PRPs that do not comply with UAOs suffer reputational damage along with four collateral consequences: EPA seeks greater penalties for PRPs that routinely do not comply with UAOs; noncompliance could make PRPs ineligible for participation in EPA programs like “Performance Track” and “Corporate Leaders”; noncompliance could lead to increased permitting times; and noncompliance impairs PRPs’ relationships with some stakeholders. The Court can easily dispose of the latter three collateral consequences GE alleges, as they are entirely hypothetical. The few courts willing to speculate that a collateral consequence will follow only do so when the consequences are inevitable.
See, e.g., Reeve Aleutian Airways, Inc. v. United States,
Remaining, then, is GE’s claim that noncompliance is accompanied by greater EPA penalties. The parties agree that EPA can and does take past UAO noncompliance into account when determining what penalties it will seek for a fresh instance of UAO noncompliance.
See
GE SUF at ¶ 132, EPA’s Response to GE SUF at ¶ 132, and GE’s Reply to EPA’s Response to GE SUF at ¶ 132. But greater penalties are not an
automatic
consequence of noneompliance.
See
Deposition of Walter Mugdan at 228:4-12; Deposition of Kenneth Patterson at 91:4-92:22. Therefore, the logic of cases like
Nat’l Council of Resistance of Iran
does not apply. Rather, the question is whether the likelihood of greater penalties will “broadly preclude” PRPs from carrying out their chosen line of business.
See Kartseva,
Still, GE has alleged sufficient pre-hear-ing, noncompliance-based deprivations for the Court to proceed to prong two of the Mathews analysis. Although GE has not pointed to a reputation-plus liberty deprivation, GE has pointed to two deprivations of protected property interests resulting from noncompliance with a UAO: damage to stock price and damage to brand value. The Court discounts Drs. Geweke’s and Johnston’s conclusions with regard to the size of those deprivations, but the Court accepts their conclusions as to the existence of those deprivations.
3. Deprivations if a PRP Complies
The question before the Court is not whether the response costs a PRP incurs if it complies with a UAO are protected property interests under the Due Process Clause. The parties agree that they are. See EPA Mem. at 21. Rather, the question is whether PRPs have a meaningful choice not to comply with a *28 UAO once it is issued. In rejecting GE’s facial challenge to section 106 in General Electric III, the Court explained that:
The ability of the PRP to choose, under the language of the statute, whether to comply with a section 106 order is key. Upon a refusal to comply with a section 106 order, EPA is powerless to deprive the PRP of property without judicial intervention. On the other hand, were the PRP to be deprived of any meaningful choice to refuse to comply with an order, that might pose a different situation in assessing whether a deprivation of property has occurred.
GE has not proposed any legal framework to analyze coercion other than the Ex parte Young standard. As discussed supra, GE has not demonstrated that EPA’s pattern and practice of administering section 106 violates Ex parte Young by unconstitutionally intimidating or coercing PRPs into compliance whenever a UAO is issued. GE has not cited to any precedent suggesting that a statute or agency policy, although not unconstitutionally coercive under Ex parte Young, can still be sufficiently coercive so as to deny one a meaningful opportunity to elect not to comply. The Court will not invent a new “lesser coercion” legal framework from scratch. Therefore, GE’s argument that PRPs are deprived of a meaningful choice — even if they are not coerced into compliance under an Ex parte Young analysis — fails as a matter of law.
GE’s argument is belied by the facts as well. GE represented at both the motions hearing and in its brief that EPA achieves a near-perfect record of compliance with UAOs.
See
Tr. at 5; GE Mem. at 50-51. GE’s expert, Dr. Rouhani, however, suggests that EPA’s record reflects a modest rate of noncompliance. Of the 5,422 PRPs who were issued UAOs between 1982 and 2006 that he examined, there were 189 instances of PRPs not complying — a rate of 3.5 percent.
See
Rouhani Report at 6.52 & Table 8(a). And of the 1,638 PRPs who have been issued UAOs most recently, there were 75 instances of noncompliance — a rate of 4.6 percent.
Id.
at Table 8(b). These rates of noncompliance mirror the kind of “acceptable rate of error” tolerated by courts,
see Shands v. Tull,
The costs of clean-up that follow compliance, paired with the pre-hearing stock price and brand value deprivations caused by noncomplianee, demonstrate that PRPs suffer pre-hearing deprivations whether or not they comply. But because the Court will not invent a new and lesser legal standard for coercion under Mathews— and GE has not demonstrated that EPA’s pattern and practice is unduly coercive under Ex parte Young — the Court holds that PRPs are not deprived of a meaningful opportunity not to comply. This conclusion is bolstered by GE’s own expert, *29 Dr. Rouhani, who demonstrates that instances of noncompliance are sufficiently numerous to suggest that PRPs are not, in fact, forced to comply.
B. Mathews Prong Two
GE has demonstrated that PRPs are deprived of at least some property interests whether or not they comply with a UAO, and hence the Court must proceed to the second prong of the
Mathews
analysis. At this stage, the Court must first identify the private interest impacted by government action, the government interest in avoiding additional pre-decision process, and the risk that the current process will result in error.
See Mathews,
The process that EPA now provides before issuing a UAO bears on the identification and balancing of these factors. Once EPA identifies a “Superfund” site, it searches for PRPs by issuing information requests and conducting interviews. EPA SOF at ¶ 5. PRPs are permitted to provide information regarding both liability and remedy selection. Id. at ¶ 6. EPA provides notice to potential PRPs through a “general notice” letter. Id. at ¶ 8. PRPs then again have the opportunity to respond to general notice letters and provide information regarding liability and remedy selection. Id. at ¶ 9. Before selecting a remedy, EPA solicits public comments and compiles an administrative record, which normally happens over the course of weeks or months. Id. at ¶¶ 13-14,18. PRPs are, of course, permitted to contribute to that record. If the remedy selected is settlement — EPA’s preferred remedy — then EPA either issues a “special notice letter” or provides other written notice to PRPs. Id. at ¶¶ 19-20. Settlement negotiations take a “significant period of time” and PRPs are normally represented by counsel. Id. at ¶¶ 21-22. PRPs are permitted to, and often do, challenge EPA’s determinations regarding liability and remedy selection during the negotiation process. Id. at ¶ 23. Finally, at the end of this lengthy process and only if negotiation fails, EPA will normally issue a UAO.
1. Private Interest
The
type
and
length
of the pre-hearing deprivation inform the constitutional relevance of the private interest.
See City of Los Angeles V. David,
Here, the significance of the pre-hearing deprivation varies depending on whether or not a PRP complies with a UAO. GE relies on the expert opinion of Dr. Shah- *30 rokh Rouhani to establish the deprivations faced by PRPs who comply with a UAO. Dr. Rouhani obtained data regarding EPA’s CERCLA enforcement activities from the Comprehensive Environmental Response, Compensation and Liability Information System (“CERCLIS”), an EPA database. Rouhani Report at ¶¶ 1.2, 4.1-4.4. Based on his assessment of that data, Dr. Rouhani opines that, on average, complying with a UAO costs a PRP $4 million. Id. at ¶¶ 2.1.3, 6.2-6.3. 15
For the costs of noncompliance with a UAO, GE relies on the expert reports from Drs. Johnston and Geweke. As discussed earlier, neither expert report properly quantifies brand value reduction or market value decline. Dr. Johnston, who addresses brand value reduction, does not attempt to quantify how much brand value drops for an average noncomplying PRP. Dr. Geweke, who addresses market value decline, opines that PRPs suffer an average $76.4 million decline in market value if they do not comply with a UAO, but he acknowledges that markets may discount potential liabilities, thereby “lessen[ing] somewhat the immediate financial impacts of a decision not to comply with a UAO.” Geweke Report at ¶27. Yet Dr. Geweke does not assess how much markets discount potential liabilities. Moreover, his $76.4 million figure is based on the unfounded assumption that EPA waits as long as possible before bringing cost recovery or enforcement actions. Therefore, the Court is left without a reliable quantification of the economic deprivations noncomplying PRPs suffer. Rather than dismissing the expert reports entirely, however, the Court is persuaded that noncomplying PRPs suffer a significant decrease in brand and market value, albeit something less than $76.4 million. The Court will proceed with the Mathews prong two assessment based on that estimate of the private interest impacted by noncompli-anee.
The deprivations that GE alleges are primarily financial ones. Financial deprivations are less troubling because money can be recouped in a post-deprivation hearing.
See David,
GE argues that PRPs are deprived of these private interests for lengthy periods of time. Under section 106(b), a complying PRP may seek reimbursement “upon completion of the required action.” On average, it takes three years to fully comply with a UAO. Rouhani Report at ¶ 6.2. Moreover, GE argues, EPA claims the power unilaterally to delay “completion.” In proceedings before the Environmental Appeals Board (“EAB”), the body that reviews section 106(b) reimbursement petitions, EPA has at times successfully argued that a petition should be dismissed because of a PRP’s failure to obtain an EPA “certificate of completion.” GE SUF at ¶ 91. In the current proceedings, however, EPA contends — correctly—that the statute does not require an EPA determination that the clean-up is complete before a complying PRP may file a reimbursement petition.
See
42 U.S.C. § 9606(b); EPA Response to GE SUF at ¶ 91. If a complying PRP believes that it has completed a clean-up but the EAB declines the PRP’s reimbursement petition for failure to obtain a certificate of completion, the PRP may appeal the EAB decision to an Article III court.
See Employers Ins. of Wausau,
GE argues that PRPs are also indefinitely “left in limbo” if they choose not to comply with a UAO. EPA has two ways to enforce UAOs under CERCLA. First, EPA can bring an enforcement action against a noncomplying PRP. Enforcement actions must be brought within five years of a “violation.”
See
28 U.S.C. § 2462. Second, EPA can complete the UAO itself and file a cost recovery petition against the PRP. Cost recovery petitions must be filed within three years of completion for removal actions and within six years of completion for remedial actions. 42 U.S.C. § 9613(g)(2). GE argues that these statutes of limitations permit an unconstitutionally long deprivation because they are paired with a “removal or remedial action [that] may itself take years to complete” such that “the government may take its own sweet time before suing.”
See
GE Mem. at 38-39 (quoting
Reardon v. United States,
In short, the relevant private interest at issue is primarily a financial one. The magnitude of the private interest depends *32 on whether or not a PRP complies, and UAOs have collateral effects on operations for some PRPs but no material impact on others. While in theory a PRP could be deprived of that private interest for several years, GE has not demonstrated that EPA in fact routinely waits as long as the CERCLA statutes of limitations allow before bringing enforcement or cost recovery actions.
2. Government Interest
Two factors are paramount in identifying the government interest. The first is whether the government has “a special need for very prompt action.”
See Fuentes v. Shevin,
EPA lacks a “special need for very prompt action” in issuing UAOs under section 106 of CERCLA.
See Fuentes,
The second consideration is the cost of the additional process GE seeks. Although GE has not outlined exactly what that additional requested process is, GE argues that some sort of neutral decision-maker is required.
See
GE Opp. at 24-25. The “most obvious solution” in GE’s view is a full judicial hearing before an Article III judge.
See
Tr. at 9:8-10:17. Judicial proceedings, however, are fraught with considerable expense and delay, and courts rarely import the judicial model into administrative decision-making.
See Mathews,
The cost of the additional process also depends on how often the government must provide it.
See Mathews,
3. Risk of Error
Analysis of the risk of error is different for a pattern and practice claim than it is for either a facial or an as-applied challenge. Case law provides scant guidance, however, on just what that difference is. The few courts that have decided pattern and practice procedural due process claims have expounded little on the risk of error analysis.
See, e.g., Haitian Refugee Ctr., Inc. v. Nelson,
According to GE, the crucial element missing from EPA’s pre-UAO issuance process is a neutral decision-maker. Although the Constitution does not
require
a neutral decision-maker,
see, e.g., Old Dominion,
Several other abstract principles suggest the pre-decisional process may result in error. The risk of error is greater when “the State stands to benefit” by taking action that deprives someone of property.
United States v. James Daniel Good Real Property,
On the other hand, some principles that GE cites do not suggest that EPA’s process is error-prone. GE argues that
ex parte
procedures, like those in
Doehr,
Still other abstract principles suggest that EPA’s process is not error-prone. Most notably, representation by counsel during the pre-decisional process sharply reduces the risk of error.
See Reeve Aleutian,
b. Concrete Evidence
Overlaid on this abstract assessment of the risk of error is the voluminous empirical record in this case. GE points to four categories of evidence drawn from that record to argue that EPA’s process in fact results in errors in issuing UAOs. First, GE proffers cases demonstrating that EPA makes mistakes in other, non-UAO contexts. Next, GE provides an expert report from Dr. Kip Viscusi, who examines whether EPA’s remedy selection is erroneous under a cost-benefit, cancer-prevention standard. Third, GE relies on declarations cataloging the experiences of several PRPs, including some sites where GE itself was issued a UAO. Finally, GE provides evidence from reimbursement proceedings filed by complying PRPs against the government.
The cases demonstrating that EPA has made mistakes in other CERCLA contexts are not informative as to EPA’s rate of error in issuing UAOs. GE cites to seven cases.
18
But none involve UAOs. Rather, they merely demonstrate that EPA has made some mistakes in administering other sections of CERCLA. That EPA makes some mistakes is unsurprising; every agency, especially one as large as EPA, makes mistakes. The APA’s “arbitrary and capricious” standard for the review of agency action anticipates that some agency errors will not warrant judicial reversal. All that courts can expect is that agency procedures “achieve an acceptable rate of error.”
See Califano v. Boles,
The expert report from Dr. Viscusi is similarly unhelpful.
19
Dr. Viscusi examined EPA’s clean-up efforts under CERC-LA from 1993 to 1999 to analyze whether EPA effectively prevents cancer from a cost-benefit perspective. Viscusi Report at ¶¶ 7, 10-13. But Dr. Viscusi’s report is at once too broad and too narrow. His report is too broad because it examines EPA’s overall administration of CERCLA. Even if Dr. Viscusi’s study reveals that EPA makes errors in its overall administration of CERCLA, that does not show that EPA errs in issuing UAOs because Dr. Viscusi did not conduct a UAO-specific analysis. The report is too narrow because it focuses only on cancer prevention and cost-benefit analysis — just two of the nine factors EPA must consider in selecting a remedy.
See
40 C.F.R. § 300.430(e)(9)(iii);
see also Ohio v. EPA
GE’s best evidence is in its declarations. In five declarations,
20
GE describes nine sites
21
where EPA supposedly erred in issuing a UAO. Five of these sites do not advance GE’s case. For the Li Tungsten site, the Grand Street Mercury site, the Fletcher’s Paint Works site, the Herington Army Airfield site, and the Woolfolk Chemical Works site, the declarants provide only their unsubstantiated assertions that a UAO either was issued to the wrong PRP or contained some improper remedy. For the Fletcher’s Paint Works site, for example, Randall McAlister, a GE Senior Program Manager, states that GE was unfairly targeted and that EPA selected an improper remedy.
See
McAlister Decl. ¶¶ 69-98. Without some independent verification that EPA in fact made errors in issuing a UAO to GE at the Fletcher’s Paint Works site, McAlister’s declaration is self-serving and uncorroborated. Such declarations are of little value at the summary judgment stage,
See Tolson v. James,
The remaining four sites do offer some support for GE’s case. GE has demonstrated that EPA’s initial remedy selection at two sites was erroneous. At the Vega Alta site, GE took issue with an EPA-proposed remedy to clean up the site. Supp. McAlister Decl. ¶¶ 18-19. GE proposed its own remedy, and EPA eventually withdrew its previous remedy and adopted GE’s approach. Id. ¶¶ 22-23. Similarly, at the Solvent Savers site, EPA replaced its initial remedy with a PRP-selected one after the PRPs demonstrated that EPA’s initial remedy was inefficient. Id. ¶¶ 30-36. At two other sites, GE has shown that EPA erroneously issued a UAO. At the Rome site, GE was issued a UAO even though GE had negotiated a clean-up plan with state environmental officials under the Resource Conservation and Recovery Act (“RCRA”), 42 U.S.C. § 6901 et seq. McAlister Decl. ¶ 134. GE was able to seek review through RCRA, and EPA withdrew the UAO before the court could act. Id. ¶¶ 146, 148. At the Palmerton Zinc Pile site, Horsehead Industries, another PRP, was issued a UAO to clean up a site that Horsehead had never owned or operated. Krablin Decl. ¶¶ 18-21. Horse-head was able to obtain review because of a parallel cost recovery action. Id. ¶ 29. The court eventually issued a consent order preliminarily enjoining enforcement of the UAO against Horsehead. Id. ¶ 31.
GE’s evidence from reimbursement proceedings is revealing but does not advance GE’s position. Under section 106(b)(2), PRPs may seek reimbursement upon completion of the cleanup if they believe that they have been issued a UAO in error. If EPA refuses to reimburse the PRP, then the PRP may file suit in a federal district court, where the PRP can challenge both liability and remedy selection.
See
42 U.S.C. §§ 9606(b)(2)(C)-(D). Given that thousands of PRPs have complied with UAOs, reimbursement proceedings would
*37
appear to be the most fertile ground for finding EPA error. But GE concedes that “there has only been one Section 106(b) case that has resulted in a final judgment adverse to EPA requiring reimbursement from the government.” GE SUF at ¶ 154. At the summary judgment stage, the paucity of evidence of error from reimbursement proceedings is telling.
See Celotex,
In sum, when all four categories of evidence proffered by GE are carefully scrutinized, GE has pointed to just five instances of error — four examples from specific sites described in GE’s declarations and one example of a complying PRP successfully obtaining reimbursement from the government. EPA has issued 1,705 UAOs to more than 5,400 PRPs since 1982.
See
Rouhani Report at ¶¶4.3, 6.5.2. If GE were attempting to present an exhaustive list of EPA’s errors in issuing UAOs, this would represent a minuscule error rate. But even if GE is not presenting an exhaustive list of EPA’s errors for all PRPs, the Court can presume that GE has at least thoroughly surveyed all 68 of the UAOs that GE itself has been issued. In the evidence presented, GE has demonstrated that EPA has made only three errors
22
in issuing those 68 UAOs — an error rate of 4.4 percent. Although not insignificant, 4.4 percent is an “acceptable rate of error” for EPA in issuing UAOs under section 106 of CERCLA.
See Shands,
4. Balancing
Having identified the private interests, government interests and risk of error, the final step in this due process assessment is to balance these factors against one another.
See Mathews,
*38 The precise nature of the interests at stake is worth repeating. The private interest depends on whether or not a PRP complies. If the PRP complies, then the average costs of compliance are $4 million and the deprivation lasts for an average of three years. If the PRP does not comply, then the average size and length of the deprivation are substantial but unclear. And whether or not a PRP complies, the deprivations are primarily financial, although for some PRPs the financial deprivations are sufficiently large to have collateral effects on operations. As for the government interest, EPA does not issue UAOs in emergency situations. But EPA nonetheless has a substantial financial and administrative interest. Because UAOs are issued frequently, even minimal additional process would tax EPA’s resources. Finally, the risk of error — as represented through the actual rate of error over many years in this pattern and practice case — is low. GE has provided concrete evidence to establish that EPA has made errors in issuing five UAOs, including three UAOs issued to GE itself. Assuming that GE has plumbed for error all 68 of the UAOs that it has received, and assuming that GE’s experience is representative, EPA makes some sort of error in roughly four percent of its UAOs.
The Court will first consider whether a pre-issuance hearing before a presiding officer within EPA would so reduce the risk of error, without unduly burdening the government interest, as to be constitutionally required. At first glance, the burden on the government interest appears minimal. For any given UAO, a hearing before a presiding officer would add only weeks or a few months to an issuance process that usually takes years.
See
Rouhani Report at ¶ 6.1.3. Moreover, the costs of a single hearing before a presiding officer are minimal, especially considering the size of the private interests at stake. But the Court may not examine the burden on the government at such a granular level.
See Gray Panthers v. Califano,
On the other hand, a pre-decision hearing by an agency presiding officer would not significantly reduce the risk of error. As demonstrated in this pattern and practice case by the low rate of error, the risk of error is already very small. The cost of additional process must indeed be minimal to justify adding to a process that already results in an acceptably low risk of error.
See Tillman v. Lebanon Cty. Correctional Facility,
Finally, the size and nature of the private interests of the PRP are not so great as to justify increased government costs with only a marginal improvement in the rate of error. Although the privates interest are significant, GE has not demonstrated that the primarily financial interests at stake here routinely have such collateral effects as to constitute a “brutal
*39
need” requiring greater pre-deprivation process.
See Arnett v. Kennedy,
This result does not change when the pre-issuance hearing is before an ALJ rather than a presiding officer. The Court’s weighing of the private interests remains unchanged. The type of hearing does not impact the size and nature of the deprivation. Nor would the impact of a hearing before an ALJ change the Court’s rate of error analysis. It is hard to reduce the rate of error when it is very low to begin with. Only the analysis of the government interest changes when considering a hearing before an ALJ instead of a presiding officer. But a pre-issuance hearing before an ALJ would increase the burden on the government interest. Hearings before an ALJ are more formal and have more of the trappings of the judicial process than informal hearings before a presiding officer. Hearings before an ALJ would undoubtedly be lengthier and more time-consuming. Because these hearings frequently would be invoked by PRPs, requiring an ALJ would constitute an even greater financial and administrative cost to the government than a hearing before a presiding officer. Based on the balancing of these factors, then, the Court concludes that the Constitution does not require a pre-issuance hearing before an ALJ either.
In summary, although GE has presented evidence of isolated errors by EPA, such infrequent errors — constituting a reasonably low overall risk of error — do not warrant the sweeping changes GE requests. Errors should be addressed by a PRP when they occur — either by not complying with a UAO and defending a subsequent enforcement proceeding or by complying with a UAO and seeking post-completion reimbursement. Those avenues remain available to PRPs under CERCLA as a more effective means to address the occasional errors revealed by the record before this Court. To the extent that GE continues to believe that EPA generally overuses or abuses UAOs, thereby overstepping its mandate, any broader remedy should be sought from Congress, not the courts.
CONCLUSION
In their motions for summary judgment, GE and EPA focus on two due process arguments: unconstitutional coercion under Ex parte Young and unconstitutional deprivation of property or liberty under Mathews v. Eldridge. For the reasons explained above, and based on the extensive record developed through years of discovery, the Court agrees with EPA on both points and concludes that GE has not shown that EPA’s pattern and practice of administering section 106 of CERCLA violates due process. Therefore, GE’s motion for summary judgment is denied and EPA’s motion for summary judgment is granted. A separate order has been issued on this date.
Notes
. EPA styled its motion as a motion for judgment on the pleadings, or alternatively, a motion for summary judgment. The same legal standard applies for each kind of motion.
See Greenhouse v. Geren,
. The Court set forth a more comprehensive discussion of the CERCLA framework in its previous opinions in this case.
See General Electric Co. v. Whitman,
. Discovery has closed in this case and the factual record is complete. At the motions hearing before this Court on October 14, 2008, counsel for GE and EPA recognized that some "details” of the factual record remain in dispute. See Transcript of Motions Hearing ("Tr.”) at 75-77, 89-91. But neither counsel maintained that these disputes would stand in the way of summary judgment. Indeed, both counsel stated that the disputed facts are not material. Moreover, both counsel recognized that the legal and factual issues in this case are not well-suited for resolution at trial. See Tr. at 75 ("I'm not sure the Court is ever going to have much more than it has right now.”); id. at 89-90 ("[W]ell, is there a need for a factual trial here[?][T]he nightmare of continuing this already long proceeding much longer, I think there is no need....").
. The Court previously indicated, but did not decide, that
Salerno
might not apply to GE's pattern and practice claim.
See General Electric III,
. EPA does not argue that GE lacks standing to challenge EPA's pattern and practice of issuing UAOs as unconstitutionally coercive under Ex parte Young.
. This standing argument is distinct from a different challenge by EPA to GE's standing to assert a pattern and practice claim at all, which the Court previously rejected.
See General Electiic III,
. Courts do not assess the merits of a plaintiff’s claim when considering standing.
See Emergency Coalition to Defend Educ. Travel v. Dep’t of Treasury,
. In a footnote, GE cited to three cases for the proposition that a statute may run afoul of
Ex parte Young
even if a penalty scheme is not automatic or self-executing.
See
GE’s Memorandum in Opposition to EPA's Summary Judgment Motion (“GE Opp.”) at 46 n.29 (citing
Chicago, M. & St. P. Rwy. Co. v. Polt,
. GE cites to
United States v. Tannery,
Civ. A.No. 91-693,
. GE’s citation to
Pearson v. Shalala,
. GE also argues in its briefs that the cost of simply responding to a UAO deprives PRPs of a protected interest. See GE Mem. at 23-25. At the motions hearing, however, counsel for GE conceded that GE does not rely on the cost of responding as a deprivation under the Mathews analysis. See Tr. at 33-34.
.
See
EPA Opp. at 15 (citing
In re N. Telecom Ltd. Secs. Litig.,
. GE argues that ''green” investors calculate that GE’s overall environmental performance impacts its financial performance. GE SUF at ¶ 19. GE does not, however, provide any evidence to suggest that noncompliance with a UAO impacts PRPs’ relationships with such investors.
. Dr. Rouhani also calculates the average costs if a PRP chooses not to comply with a UAO. Assuming that EPA cleans up a site itself, brings an enforcement action against the noncomplying PRP, and persuades a court to award punitive damages and the maximum daily fines for the average period of completion, Dr. Rouhani calculates that the average costs of noncompliance are more than $54 million. Rouhani Report at ¶ 6.3.5. But because PRPs receive a full judicial hearing before any of those costs may be imposed, those costs of noncompliance do not factor into an assessment of whether more process is needed before a UAO may be issued.
. Whether or not "imminent and substantial” is synonymous with "emergency” as a legal matter is an issue this Court need not decide.
. Dr. Rouhani points out that UAOs have been issued more frequently in the past 15 years than they were for the first ten years. See Rouhani Report at 6.7. The Court’s calculation, therefore, underestimates the number of UAOs EPA currently issues per month.
.
United States v. Burlington N. R.R. Co.,
. Indeed, GE’s counsel indicated at the motions hearing that Dr. Viscusi's report is primarily intended to show that political factors influence EPA’s decision-making process, not that EPA in fact makes errors in issuing UAOs. See Tr. at 46; see also GE SUF at ¶¶ 68-69.
. Declaration of Richard Krablin; Declaration of John Baker; Declaration of Daniel Uyesato; Declaration of Randall McAlister; and Supplemental Declaration of Randall McAlister.
. The Grand Street Mercury Superfund site; the Fletcher’s Paint Works site; the former GE electrical transformer manufacturing facility in Rome, Ga. ("Rome site”); the Vega Alta Superfund site; the Solvent Savers Superfund site; the Li Tungsten site; the Wool-folk Chemical Works site; the Herington Army Airfield site; and the Palmerton Zinc Pile Superfund site.
. Those are alleged errors at the Vega Alta site, the Solvent Savers site, and the Rome site.
. If neither a presiding agency officer nor an ALJ as a neutral decision-maker is constitutionally required for the section 106 UAO pre-issuance process, then the substantially more burdensome full judicial hearing would not be necessary either.
